Ensysce Biosciences Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 13 institutions reported holding Ensysce Biosciences Inc. in their 13F filings, up 3 from Q2 2024. 6 opened new positions and 3 sold out. The largest holders were Sabby Management, LLC ($279K), Anson Funds Management LP ($236K) and UBS Group AG ($27K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Ensysce Biosciences Inc.
- CUSIP
- 293602405
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $279K |
| Exits | 3 | $13K |
All 13F filers, Q2 2024 → Q3 2024: 2,011,831 shares bought and 89,513 shares sold, net +1,922,318 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Sabby Management, LLC | 3.88% | Add +269.8% | 1,162,592 | $279K |
| Anson Funds Management LP | 0.03% | New | 983,518 | $236K |
| UBS Group AG | 0.00% | New | 112,682 | $27K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.1% | 46,072 | $11K |
| Citadel Advisors | 0.00% | Reduce -72.7% | 23,605 | $6K |
| Renaissance Technologies | 0.00% | New | 22,400 | $5K |
| Cerity Partners LLC | 0.00% | New | 21,426 | $5K |
| HRT Financial LP | 0.00% | New | 23,558 | $5K |
| Vanguard Group Inc. | 0.00% | No change | 18,175 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -21.8% | 6,454 | $2K |
| BlackRock, Inc. | 0.00% | — | 975 | $234 |
| Bank of America Corp. | 0.00% | Add +11.3% | 69 | $17 |
| FMR LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is ENSYSCE BIOSCIENCES INC's weight in each manager's 13F, not the share of Ensysce Biosciences Inc. the manager owns.